The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss

Author： Rowe Rachel Cowx Margaret Poole Chris McEwan Phil Morgan Christopher Walker Mel

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.11, 2005-11, pp. : 1885-1890

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta‐analysis of randomized controlled trials

OBESITY REVIEWS, Vol. 16, Iss. 12, 2015-12 ,pp. : 1071-1080

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of insulin glargine treatment and an educational programme on glycaemic control in type 2 diabetes patients in clinical practice

By Schreiber Stephan A. Russmann Anika

Current Medical Research and Opinion, Vol. 22, Iss. 2, 2006-02 ,pp. : 335-341

Informa Healthcare

Access to resources Recommend Favorite

The effects of good glycaemic control on left ventricular and coronary endothelial functions in patients with poorly controlled Type 2 diabetes mellitus

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 3, 2015-03 ,pp. : 388-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Continuous intraperitoneal insulin infusion in patients with ‘brittle’ diabetes: favourable effects on glycaemic control and hospital stay

DIABETIC MEDICINE, Vol. 19, Iss. 6, 2002-06 ,pp. : 496-501

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel and selective sodium‐glucose cotransporter‐2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 1462-8902, Iss. 10, 2015-10 ,pp. : 984-993

John Wiley & Sons Inc

Access to resources Recommend Favorite